Posters

Vein occlusions: management and follow-up

Poster Details

First Author: N.Tsaldari GREECE

Co Author(s): K. Giannoukaki   F. Akritidou   S. Roumelis   A. Karachalios   C. Karagiannidis        

Abstract Details

Purpose:

To present the retinal vein occlusion (RVO) incidences we examined at the General Hospital of Serres, the management we followed and their long-term outcome.

Setting:

Department of Opthalmology, General Hospital of Serres, Greece.

Methods:

25 patients with retinal vein occlusion underwent complete ophthalmic examination including: Best Corrected Visual Acuity (BCVA) with Snellen’s chart, anterior segment evaluation, tonometry, fundoscopy exam (fully dilated), Optical Coherence Tomography (OCT) . Additionally, clinical and laboratory testing was performed so as to detect predisposing factors. The follow-up was done at 15 d., 30d., 2m, 3m, 6m, 12m. Patients were devided in two groups: 14 that were ischaemic RVO and 11 that were non-ischaemic RVO.

Results:

The mean BCVA of all patients in the first examination was < 3/10 with typical funduscopy findings. At non-ischaemic cases, no intervention was needed. According to the OCT results, patients with ischaemic RVO were treated with intravitreal anti-VEGF agents, beginning with a 3 monthly dosing followed by the treat and extend approach. At the 12 m. follow-up : The non-ischaemic fully recovered, not showing any remission. 64% of the ischaemic cases showed improvement (gaining between 2 and 6 Snellen lines), 27% had no improvement and 9% suffered from frequent relapses requiring closer monitoring and further intervention.

Conclusions:

Retinal vein occlusions are a severe and one of the most often encountered retinopathies. Although the non-ischaemic cases have an excellent prognosis, the same doesn’t apply for the ischaemic ones. Careful follow-up is needed in all cases at least for 6 months. Keeping in mind that in some cases further follow up for up to 12 m. is needed so as to early detect relapses.

Financial Disclosure:

None